Skip to content
Pharma Observatory a Scientist.com platform

Organization (Academic)

University of Missouri System

ClinicalTrials.gov lists University of Missouri System as lead sponsor of 53 trials, counting the companies grouped under it.

US Manufacturer
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Companies grouped under this page Companies grouped under this page 2 Related companies not grouped here Related companies not grouped here 1 Disease areas Disease areas 293 Journals published in Journals published in 692 US granted patents US granted patents 1 Financing and grant events Financing and grant events 1,078 FDA inspection record FDA inspection record 1 Organization relationships Organization relationships 58 Companies grouped under this page Companies grouped under this page 2 Related companies not grouped here Related companies not grouped here 1 Disease areas Disease areas 293 Journals published in Journals published in 692 US granted patents US granted patents 1 Financing and grant events Financing and grant events 1,078 FDA inspection record FDA inspection record 1 Organization relationships Organization relationships 58

Rows recorded per section (log scale)

2 more sections with rows · 14 sections measured, none recorded

This page covers University of Missouri System and 2 companies grouped under it: 53 lead-sponsored trials (0 its own, 53 in the grouped companies) and 3 legal-entity registrations (1 its own, 2 in the grouped companies).

Related companies are recorded in the same corporate group by GLEIF, ROR or a curator but are not grouped here; they are listed below with their own counts and are not included in the figures above.

Get the University of Missouri System report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Companies grouped under this page (2)

Shown in this order: most lead trials first.

Companies grouped under this page
Company Lead trials Legal entities
University of Missouri–Kansas City 48 1
University of Missouri–St. Louis 5 1

Disease areas (293)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Obesity 51
Pain 32
Diabetes Mellitus 31
Insulin Resistance 24
Sleep Initiation and Maintenance Disorders 20

Journals published in (692)

Shown in this order: most published in first.

Journals published in
Journal Publications
The New England journal of medicine 17
Circulation 15
The Cochrane database of systematic reviews 15
Journal of shoulder and elbow surgery 13
The Journal of nutrition 12

US granted patents (1)

Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.

US granted patents
US patents granted Granted in the last 5 years Most recent grant
19 1 2023-05-16

Financing and grant events (1,078)

Shown in this order: most recent first.

Financing and grant events
Date Round type Amount (USD) Source
2025-09-19 NIH grant 855,881 Reporter
2025-09-16 NIH grant 50,000 Reporter
2025-09-15 NIH grant 577,136 Reporter
2025-09-12 NIH grant 247,802 Reporter
2025-09-11 NIH grant 570,174 Reporter

FDA inspection record (1)

FDA inspection record
Latest classification Inspections
VAI 6

Organization relationships (58)

Shown in this order: most evidence first.

Organization relationships
Related organization Relationship Evidence
Government of the United States of America Co sponsors trial with 11
University of California System Co sponsors trial with 3
Mount Sinai Health System Co sponsors trial with 3
The University of Texas System Co sponsors trial with 2
National Multiple Sclerosis Society Co sponsors trial with 2

Latest dated events (1,618)

Shown in this order: newest first.

Latest dated events
Date Event Source
2027-01-04 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2027-01-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-12-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-10 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-10-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Biomarkers this organization publishes on (831)

Shown in this order: most publications first.

Biomarkers this organization publishes on
Biomarker Publications
INS 50
IL6 32
TNF 29
CRP 24
SLC5A2 24

On Scientist.com

University of Missouri System is listed as a research supplier in the Scientist.com network.

Source: Scientist.com supplier network

Not on this page

Checked, with nothing recorded for this organization: trials by start year as sponsor or collaborator, active development programs, approved assets, sponsor delivery record, sec-reported annual financials, fda warning letters, fda untitled letters, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, and biomarker capability evidence.

Work with Missouri University of Science and Technology on Scientist.com

For prices, more details, or to contact Missouri University of Science and Technology, visit Scientist.com.

Sign in to Scientist.com to open this supplier in your organization's marketplace.